JP2015509963A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015509963A5 JP2015509963A5 JP2014560384A JP2014560384A JP2015509963A5 JP 2015509963 A5 JP2015509963 A5 JP 2015509963A5 JP 2014560384 A JP2014560384 A JP 2014560384A JP 2014560384 A JP2014560384 A JP 2014560384A JP 2015509963 A5 JP2015509963 A5 JP 2015509963A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- motomeko
- toxoid
- composition
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims description 41
- 239000002671 adjuvant Substances 0.000 claims description 14
- 239000000427 antigen Substances 0.000 claims description 10
- 102000036639 antigens Human genes 0.000 claims description 10
- 108091007433 antigens Proteins 0.000 claims description 10
- 150000001720 carbohydrates Chemical class 0.000 claims description 9
- 241000991587 Enterovirus C Species 0.000 claims description 8
- 201000005702 Pertussis Diseases 0.000 claims description 8
- 229960003983 diphtheria toxoid Drugs 0.000 claims description 8
- 229960000814 tetanus toxoid Drugs 0.000 claims description 8
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims description 7
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 claims description 6
- 241000588650 Neisseria meningitidis Species 0.000 claims description 6
- 102100039360 Toll-like receptor 4 Human genes 0.000 claims description 6
- 239000000556 agonist Substances 0.000 claims description 6
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 4
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 claims description 4
- 230000002163 immunogen Effects 0.000 claims description 4
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 2
- 241000700721 Hepatitis B virus Species 0.000 claims description 2
- 108700026633 Neisseria meningitidis factor H-binding Proteins 0.000 claims description 2
- 229960002897 heparin Drugs 0.000 claims description 2
- 229920000669 heparin Polymers 0.000 claims description 2
- 230000028993 immune response Effects 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 230000001268 conjugating effect Effects 0.000 claims 2
- 208000018756 Variant Creutzfeldt-Jakob disease Diseases 0.000 description 2
- 208000005881 bovine spongiform encephalopathy Diseases 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000024777 Prion disease Diseases 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261608409P | 2012-03-08 | 2012-03-08 | |
| US61/608,409 | 2012-03-08 | ||
| US201261697745P | 2012-09-06 | 2012-09-06 | |
| US61/697,745 | 2012-09-06 | ||
| PCT/EP2013/054674 WO2013132043A1 (en) | 2012-03-08 | 2013-03-08 | Combination vaccines with tlr4 agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015509963A JP2015509963A (ja) | 2015-04-02 |
| JP2015509963A5 true JP2015509963A5 (enExample) | 2016-04-28 |
Family
ID=47844315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014560384A Pending JP2015509963A (ja) | 2012-03-08 | 2013-03-08 | Ｔｌｒ４アゴニストを含む混合ワクチン |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20150125486A1 (enExample) |
| EP (1) | EP2822584A1 (enExample) |
| JP (1) | JP2015509963A (enExample) |
| CN (1) | CN104159603A (enExample) |
| WO (1) | WO2013132043A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0822633D0 (en) * | 2008-12-11 | 2009-01-21 | Novartis Ag | Formulation |
| CN104093418A (zh) * | 2011-09-01 | 2014-10-08 | 诺华股份有限公司 | 金黄色葡萄球菌抗原的含佐剂制剂 |
| CA3081581A1 (en) * | 2017-11-03 | 2019-05-09 | Takeda Vaccines, Inc. | Method for inactivating zika virus and for determining the completeness of inactivation |
| AU2018375173B2 (en) | 2017-11-30 | 2022-08-25 | Takeda Vaccines, Inc. | Zika vaccines and immunogenic compositions, and methods of using the same |
| BR112020016314A2 (pt) | 2018-02-12 | 2020-12-15 | Inimmune Corporation | Compostos ou um sais farmaceuticamente aceitáveis, composição farmacêutica, kit, e, métodos para elicitar, intensificar ou modificar uma resposta imunológica, para tratar, prevenir ou reduzir a suscetibilidade a câncer, para tratar, prevenir ou reduzir a suscetibilidade a uma doença infecciosa, para tratar, prevenir ou reduzir a suscetibilidade a uma alergia, para tratar, prevenir ou reduzir a suscetibilidade a uma afecção autoimune, para tratar, prevenir ou reduzir a suscetibilidade em um sujeito à infecção bacteriana, viral, priônica, autoimunidade, câncer ou alergia, para tratar, prevenir ou reduzir a suscetibilidade à autoimunidade, alergia, reperfusão de isquemia ou sepse, para tratar, prevenir ou reduzir a gravidade de ataques epiléticos e para tratar, prevenir ou reduzir a suscetibilidade a doenças oculares como degeneração macular, hipertensão ocular e infecção ocular |
| CN113395977A (zh) * | 2018-12-05 | 2021-09-14 | 圣诺菲·帕斯图尔公司 | 百日咳加强疫苗 |
| AU2020278777A1 (en) * | 2019-05-23 | 2021-12-16 | The University Of Montana | Vaccine adjuvants based on TLR receptor ligands |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4057685A (en) | 1972-02-02 | 1977-11-08 | Abbott Laboratories | Chemically modified endotoxin immunizing agent |
| US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
| US4459286A (en) | 1983-01-31 | 1984-07-10 | Merck & Co., Inc. | Coupled H. influenzae type B vaccine |
| US4663160A (en) | 1983-03-14 | 1987-05-05 | Miles Laboratories, Inc. | Vaccines for gram-negative bacteria |
| US4761283A (en) | 1983-07-05 | 1988-08-02 | The University Of Rochester | Immunogenic conjugates |
| US4808700A (en) | 1984-07-09 | 1989-02-28 | Praxis Biologics, Inc. | Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers |
| IT1187753B (it) | 1985-07-05 | 1987-12-23 | Sclavo Spa | Coniugati glicoproteici ad attivita' immunogenica trivalente |
| US5204098A (en) | 1988-02-16 | 1993-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Polysaccharide-protein conjugates |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| NL8802046A (nl) | 1988-08-18 | 1990-03-16 | Gen Electric | Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen. |
| EP0378881B1 (en) | 1989-01-17 | 1993-06-09 | ENIRICERCHE S.p.A. | Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines |
| FI920131A0 (fi) | 1989-07-14 | 1992-01-13 | Praxis Biolog Inc | Cytokin- och hormonbaerare foer konjugatvaccin. |
| IT1237764B (it) | 1989-11-10 | 1993-06-17 | Eniricerche Spa | Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici. |
| SE466259B (sv) | 1990-05-31 | 1992-01-20 | Arne Forsgren | Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal |
| DE69113564T2 (de) | 1990-08-13 | 1996-05-30 | American Cyanamid Co | Faser-Hemagglutinin von Bordetella pertussis als Träger für konjugierten Impfstoff. |
| US5153312A (en) | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
| IT1262896B (it) | 1992-03-06 | 1996-07-22 | Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini. | |
| JP3626996B2 (ja) * | 1992-05-23 | 2005-03-09 | グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム | Ｂ型肝炎表面抗原および他の抗原からなる複合ワクチン |
| IL102687A (en) | 1992-07-30 | 1997-06-10 | Yeda Res & Dev | Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them |
| CA2142981C (en) | 1992-08-31 | 2007-10-23 | Joseph Y. Tai | Vaccines against group c neisseria meningitidis |
| US5425946A (en) | 1992-08-31 | 1995-06-20 | North American Vaccine, Inc. | Vaccines against group C Neisseria meningitidis |
| EP0689454B2 (en) | 1993-03-23 | 2005-02-23 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| DE69615362T3 (de) | 1995-06-07 | 2006-07-20 | Smithkline Beecham Biologicals S.A. | Impfstoff mit einem polysaccharidantigen-trägerprotein-konjugat und einem trägerprotein |
| US6299881B1 (en) | 1997-03-24 | 2001-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts |
| GB9713156D0 (en) | 1997-06-20 | 1997-08-27 | Microbiological Res Authority | Vaccines |
| GB9806456D0 (en) * | 1998-03-25 | 1998-05-27 | Smithkline Beecham Biolog | Vaccine composition |
| CN100379757C (zh) | 1998-05-01 | 2008-04-09 | 希龙公司 | 脑膜炎奈瑟球菌抗原和组合物 |
| NZ509986A (en) | 1998-08-19 | 2003-10-31 | Baxter Healthcare S | Immunogenic beta-propionamido-linked polysaccharide and oligosaccharide protein conjugates as vaccines |
| US20030130212A1 (en) | 1999-01-14 | 2003-07-10 | Rossignol Daniel P. | Administration of an anti-endotoxin drug by intravenous infusion |
| US6551600B2 (en) | 1999-02-01 | 2003-04-22 | Eisai Co., Ltd. | Immunological adjuvant compounds compositions and methods of use thereof |
| KR100642044B1 (ko) | 1999-03-19 | 2006-11-10 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 백신 |
| EP1165796A2 (en) | 1999-04-09 | 2002-01-02 | Techlab, Inc. | Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines |
| ES2307553T3 (es) | 1999-12-02 | 2008-12-01 | Novartis Vaccines And Diagnostics, Inc. | Composiciones y procedimientos para estabilizar moleculas biologicas tras liofilizacion. |
| GB0007432D0 (en) | 2000-03-27 | 2000-05-17 | Microbiological Res Authority | Proteins for use as carriers in conjugate vaccines |
| GB0108364D0 (en) * | 2001-04-03 | 2001-05-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
| OA12302A (en) * | 2000-06-29 | 2003-10-24 | Glaxosmithkline Biolog Sa | Multivalent vaccine composition. |
| EP2957300B1 (en) | 2001-01-23 | 2021-07-14 | Sanofi Pasteur Inc. | Multivalent meningococcal polysaccharide-protein conjugate vaccine |
| AU2002309706A1 (en) | 2001-05-11 | 2002-11-25 | Aventis Pasteur, Inc. | Novel meningitis conjugate vaccine |
| GB0115176D0 (en) | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
| GB0202901D0 (en) | 2002-02-07 | 2002-03-27 | Glaxosmithkline Biolog Sa | Novel vaccine |
| WO2003080678A1 (en) | 2002-03-26 | 2003-10-02 | Chiron Srl | Modified saccharides having improved stability in water |
| GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| BRPI0411815A (pt) | 2003-06-23 | 2006-08-08 | Baxter Int | vacinas contra neisseria meningitidis do tipo y e suas combinações meningocócicas |
| GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
| EP1866342B1 (en) | 2005-04-08 | 2018-11-21 | Wyeth LLC | Separation of contaminants from streptococcus pneumoniae polysaccharide by ph manipulation |
| US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| KR102378962B1 (ko) | 2005-04-08 | 2022-03-28 | 와이어쓰 엘엘씨 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
| US7955605B2 (en) | 2005-04-08 | 2011-06-07 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US20070184072A1 (en) | 2005-04-08 | 2007-08-09 | Wyeth | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US9486515B2 (en) | 2005-06-27 | 2016-11-08 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
| WO2007053455A2 (en) | 2005-10-28 | 2007-05-10 | Vaxinnate Corporation | Polypeptide ligans for toll-like receptor 4 (tlr4) |
| GB0522765D0 (en) | 2005-11-08 | 2005-12-14 | Chiron Srl | Combination vaccine manufacture |
| CN103251940A (zh) | 2005-12-22 | 2013-08-21 | 葛兰素史密丝克莱恩生物有限公司 | 疫苗 |
| GB0616306D0 (en) * | 2006-08-16 | 2006-09-27 | Novartis Ag | Vaccines |
| EP2491947A3 (en) | 2006-09-07 | 2012-10-17 | GlaxoSmithKline Biologicals S.A. | Vaccine |
| CN102648979B (zh) | 2006-10-10 | 2014-05-14 | 惠氏公司 | 肺炎链球菌3型多糖的纯化 |
| CN103313725B (zh) | 2010-09-01 | 2016-06-29 | 诺华有限公司 | 免疫增强剂吸附不溶性金属离子 |
| KR20140026392A (ko) * | 2011-03-02 | 2014-03-05 | 노파르티스 아게 | 저용량의 항원 및/또는 보조제를 갖는 조합 백신 |
-
2013
- 2013-03-08 CN CN201380012958.6A patent/CN104159603A/zh active Pending
- 2013-03-08 EP EP13708414.1A patent/EP2822584A1/en not_active Withdrawn
- 2013-03-08 US US14/381,438 patent/US20150125486A1/en not_active Abandoned
- 2013-03-08 JP JP2014560384A patent/JP2015509963A/ja active Pending
- 2013-03-08 WO PCT/EP2013/054674 patent/WO2013132043A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014506916A5 (enExample) | ||
| JP2015509963A5 (enExample) | ||
| JP5637848B2 (ja) | 髄膜炎ワクチンの製剤化 | |
| JP4870895B2 (ja) | ワクチン組成物 | |
| TWI281403B (en) | Vaccine | |
| RU2013144207A (ru) | Комбинированные вакцины с пониженными дозами антигена и/или адъюванта | |
| US20130251745A1 (en) | Vaccine | |
| JP2005508849A5 (enExample) | ||
| JP2012506421A5 (enExample) | ||
| JP2015531389A5 (enExample) | ||
| RU2008112289A (ru) | Множественная вакцинация, включающая менингококки серогруппы с | |
| JP5401012B2 (ja) | Ｂ型インフルエンザ菌糖ワクチン用ポリアニオン性ポリマーアジュバント | |
| JP2010529103A5 (enExample) | ||
| RU2008123006A (ru) | Получение вакцин, содержащих поверхностный антиген вируса гепатита в и поверхностно-активное вещество | |
| JP2009525260A5 (enExample) | ||
| KR20090058552A (ko) | 백신 | |
| EP1066053A1 (en) | Hib/dtpa vaccine composition and methods of preparation | |
| JP2010163453A5 (enExample) | ||
| US20090311285A1 (en) | Vaccine | |
| RU2006142156A (ru) | Объединенные менингококковые конъюгаты с общим белком-носителем | |
| RU2015106745A (ru) | Иммуногенные композиции | |
| PT1858551E (pt) | Vacinas combinadas com antigénio de célula inteira da tosse convulsa (pertussis) | |
| JP2015509963A (ja) | Ｔｌｒ４アゴニストを含む混合ワクチン | |
| US20150320852A1 (en) | Conjugates for protecting against diphtheria and/or tetanus | |
| US20030022304A1 (en) | Vaccine composition |